Clinical Trial Update: VIBRANT: VIB4920 for Active Lupus Nephritis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating VIB4920 for active lupus nephritis is currently recruiting, sponsored by the National Institute of Allergy and Infectious Diseases (N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• VIB4920 (VIB4920)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Lupus Nephritis | Phase 2 | Status: RECRUITING